Navigation Links
Roche Offers Innovative Website Designed to Empower Cancer Patients
Date:10/31/2007

-Interactive Online Resource Provides Customized Oral Chemotherapy

Information-

NUTLEY, N.J., Oct. 31 /PRNewswire/ -- Maximizing on the momentum gained during Breast Cancer Awareness Month, healthcare providers and advocacy organizations now have a helpful resource to offer cancer patients -- OralChemoAdvisor.com -- an educational, state-of-the-art Web site about oral chemotherapy. This straightforward, credible site is designed to help cancer patients and their family members make more informed healthcare decisions concerning oral chemotherapy treatment.

"There is a general lack of awareness about oral chemotherapy as a treatment option despite the overwhelming amount of resources dedicated to cancer patients," said Lars E. Birgerson, Vice President of Medical Affairs at Roche, which created and launched the site. "OralChemoAdvisor.com is specifically designed to help patients locate relevant information to help them better understand and assist in managing their treatment."

OralChemoAdvisor.com offers direct and easy access to a variety of educational tools designed to help patients who want to learn more about oral chemotherapy and its efficacy, risks and benefits. The site contains a unique video component that gives patients the option of interacting with oncology medical professionals and helps ensure that new information is retained. The expert videos include guides on oral chemotherapy treatment and patient-doctor communication, both of which also are available in written form. And, OralChemoAdvisor.com offers a list of oral chemotherapy treatments indicated for specific types of cancer, answers to frequently asked questions, and expert insights on cancer management and treatment.

"It is so important for breast cancer patients to have access to the most up-to-date information and resources. Web sites such as oralchemoadvisor.com are an important option for patients to help them make informed
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Roche Commits More Antiviral Pills To Asia For Bird Flu
3. FDA Imposes New Restrictions On Roches Accutane
4. Roche confirms Tamiflu production talks in US
5. Distinguished Scientist Award Conferred on University of Rochester Scientists for Work on Preventing Cavities
6. Roche Rolls Out Lung Cancer Drug In India
7. New Lung Cancer Drug Launched By Roche Pharmaceutical
8. Roche Calls For Re-Examination Of Tarceva Data By EU Authorities
9. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
10. NICE Gives the Final ‘NO’ to Roche’s Tarcva
11. Roche Announces Major Recall of HIV Drug
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 1Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 2Arctic Sun Again Preferred Choice of Top Ranked U S Hospitals for Therapeutic Temperature Management 56520 3New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Groups American subsidiary Helsinn Therapeutics 28U S 29 In 56516 1New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Groups American subsidiary Helsinn Therapeutics 28U S 29 In 56516 2Capture Billing Increases Network Security to Help Protect Patient Records 56515 1Capture Billing Increases Network Security to Help Protect Patient Records 56515 2